Sage Journals: Discover world-class research

Open access

Research article

First published 2017-9

Comparative efficacy and discontinuation of dimethyl fumarate and fingolimod in clinical practice at 24-month follow-up

Carrie M Hersh, Thomas E Love, Anasua Bandyopadhyay [...]

Multiple Sclerosis Journal – Experimental,Translational and Clinical

Retricted access

Case report

First published 2018-7

Fulminant rebound of relapsing–remitting multiple sclerosis after discontinuation of dimethyl fumarate: A case report

Peter Harmel, Frieder Schlunk, Lutz Harms

Multiple Sclerosis Journal

Open access

Research article

First published 2020-10

Effect of tobacco use on disease activity and DMT discontinuation in multiple sclerosis patients treated with dimethyl fumarate or fingolimod

Carrie M Hersh, Haleigh Harris, Malissa Ayers [...]

Multiple Sclerosis Journal – Experimental,Translational and Clinical

Open access

Research article

First published 2021-4

Real-world discontinuation rate of teriflunomide and dimethyl fumarate in multiple sclerosis

Hilde Norborg, Trond Riise, Kjell-Morten Myhr [...]

Multiple Sclerosis Journal – Experimental,Translational and Clinical

Retricted access

Case report

First published 2021-7

Persistent severe lymphopenia 5 years after dimethyl fumarate discontinuation

Natalia Gonzalez Caldito, Shirley O’Leary, Olaf Stuve

Multiple Sclerosis Journal

Open access

Research article

First published 2022-7

Overall and patient-level comparative effectiveness of dimethyl fumarate and fingolimod: A precision medicine application to the Observatoire Français de la Sclérose en Plaques registry

Gabrielle Simoneau, Xiaotong Jiang, Fabien Rollot [...]

Multiple Sclerosis Journal – Experimental,Translational and Clinical

Retricted access

Article commentary

First published 2021-7

Persisting lymphopenia and dimethyl fumarate: A clinical commentary

Lara Diem, Andrew Chan

Multiple Sclerosis Journal

Open access

Research article

First published 2019-4

Efficacy and safety of dimethyl fumarate in treatment-naïve Japanese patients with multiple sclerosis: Interim analysis of the randomized placebo-controlled study

Masahiro Mori, Takashi Ohashi, Yasuhiro Onizuka [...]

Multiple Sclerosis Journal – Experimental,Translational and Clinical

Retricted access

Review article

First published 2013-12

Dimethyl Fumarate (Tecfidera)

Jineane V. Venci, Mona A. Gandhi

Annals of Pharmacotherapy

Open access

Research article

First published 2023-2

Comparative effectiveness of cladribine tablets versus other oral disease-modifying treatments for multiple sclerosis: Results from MSBase registry

Tim Spelman, Serkan Ozakbas, Raed Alroughani [...]

Multiple Sclerosis Journal

Search results